Genomictree Inc. (KOSDAQ:228760)

Genomictree Ratios and Metrics

Market cap in millions KRW. Fiscal year is January - December.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Apr 9, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Market Capitalization	411,561	659,414	490,598	486,819	181,477	270,356
Market Cap Growth	-7.87%	34.41%	0.78%	168.25%	-32.88%	-7.66%
Enterprise Value	336,802	576,582	396,622	392,442	88,761	154,638
Last Close Price	16960.00	27450.00	20450.00	20600.00	8790.00	13300.00
PS Ratio	109.46	175.37	207.68	142.43	6.08	52.60
PB Ratio	3.57	5.72	3.95	3.89	1.69	2.35
P/TBV Ratio	3.62	5.79	4.00	3.95	1.72	2.39
P/FCF Ratio	-	-	-	-	71.93	-
P/OCF Ratio	-	-	-	-	42.35	-
EV/Sales Ratio	89.57	153.34	167.90	114.82	2.97	30.09
EV/EBITDA Ratio	-	-	-	-	23.73	-
EV/EBIT Ratio	-	-	-	-	36.90	-
EV/FCF Ratio	-26.07	-	-	-	35.18	-
Debt / Equity Ratio	0.02	0.02	0.02	0.02	0.27	0.33
Debt / EBITDA Ratio	-	-	-	-	7.80	-
Debt / FCF Ratio	-	-	-	-	11.57	-
Net Debt / Equity Ratio	-0.65	-0.65	-0.76	-0.73	-0.79	-0.80
Net Debt / EBITDA Ratio	7.33	7.33	6.65	5.66	-22.84	10.43
Net Debt / FCF Ratio	5.81	5.81	5.83	8.21	-33.86	4.95
Asset Turnover	0.03	0.03	0.02	0.02	0.18	0.04
Inventory Turnover	10.21	10.21	7.48	6.57	10.63	3.48
Quick Ratio	17.55	17.55	20.35	17.77	2.17	62.01
Current Ratio	17.75	17.75	20.56	18.06	2.21	62.71
Return on Equity (ROE)	-7.62%	-7.62%	-8.33%	-7.75%	-5.60%	-10.86%
Return on Assets (ROA)	-5.62%	-5.62%	-7.26%	-7.31%	0.88%	-4.17%
Return on Capital Employed (ROCE)	-9.70%	-9.70%	-12.20%	-13.60%	2.20%	-5.60%
Earnings Yield	-2.18%	-1.36%	-2.09%	-1.80%	-3.65%	-4.23%
FCF Yield	-3.14%	-1.96%	-3.28%	-2.28%	1.39%	-6.88%
Buyback Yield / Dilution	-0.63%	-0.63%	9.93%	-26.28%	-1.68%	-3.30%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.